![Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro | Acta Pharmacologica Sinica Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro | Acta Pharmacologica Sinica](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Faps.2015.42/MediaObjects/41401_2015_Article_BFaps201542_Fig1_HTML.jpg)
Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro | Acta Pharmacologica Sinica
![Epigenomes | Free Full-Text | One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies | HTML Epigenomes | Free Full-Text | One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies | HTML](https://www.mdpi.com/epigenomes/epigenomes-05-00022/article_deploy/html/images/epigenomes-05-00022-g001.png)
Epigenomes | Free Full-Text | One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies | HTML
![POR | Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers POR | Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers](https://www.por-journal.com/files/Articles/1610276/pore-28-1610276-HTML-r1/image_m/pore-28-1610276-g002.jpg)
POR | Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers
![Siobhan GLAVEY | Professor of Pathology | MB BCh BAO BSc MRCPI PhD FRCPath | Royal College of Surgeons in Ireland, Dublin | RCSI | Haematology Siobhan GLAVEY | Professor of Pathology | MB BCh BAO BSc MRCPI PhD FRCPath | Royal College of Surgeons in Ireland, Dublin | RCSI | Haematology](https://www.researchgate.net/publication/330819630/figure/fig1/AS:721745220747265@1549088878713/Hyponatraemia-during-anti-MM-treatment-and-response-to-tolvaptan-therapy_Q320.jpg)
Siobhan GLAVEY | Professor of Pathology | MB BCh BAO BSc MRCPI PhD FRCPath | Royal College of Surgeons in Ireland, Dublin | RCSI | Haematology
![Cells | Free Full-Text | Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma | HTML Cells | Free Full-Text | Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma | HTML](https://www.mdpi.com/cells/cells-10-00448/article_deploy/html/images/cells-10-00448-g002.png)
Cells | Free Full-Text | Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma | HTML
![Epigenomes | Free Full-Text | One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies | HTML Epigenomes | Free Full-Text | One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies | HTML](https://www.mdpi.com/epigenomes/epigenomes-05-00022/article_deploy/html/images/epigenomes-05-00022-ag.png)
Epigenomes | Free Full-Text | One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies | HTML
![Cells | Free Full-Text | Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma | HTML Cells | Free Full-Text | Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma | HTML](https://www.mdpi.com/cells/cells-10-00448/article_deploy/html/images/cells-10-00448-g003.png)
Cells | Free Full-Text | Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma | HTML
![The HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma The HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma](https://oaepublishstorage.blob.core.windows.net/29260569-e0a1-4a0f-ab79-8661a0d2e14f/4362.fig.1.jpg)
The HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma
![The HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma The HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma](https://oaepublishstorage.blob.core.windows.net/29260569-e0a1-4a0f-ab79-8661a0d2e14f/4362.fig.2.jpg)
The HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma
![Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products - Natural Product Reports (RSC Publishing) DOI:10.1039/C9NP00052F Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products - Natural Product Reports (RSC Publishing) DOI:10.1039/C9NP00052F](https://pubs.rsc.org/image/article/2020/NP/c9np00052f/c9np00052f-f1_hi-res.gif)
Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products - Natural Product Reports (RSC Publishing) DOI:10.1039/C9NP00052F
![Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products - Natural Product Reports (RSC Publishing) DOI:10.1039/C9NP00052F Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products - Natural Product Reports (RSC Publishing) DOI:10.1039/C9NP00052F](https://pubs.rsc.org/image/article/2020/NP/c9np00052f/c9np00052f-f3_hi-res.gif)
Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products - Natural Product Reports (RSC Publishing) DOI:10.1039/C9NP00052F
![Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products - Natural Product Reports (RSC Publishing) DOI:10.1039/C9NP00052F Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products - Natural Product Reports (RSC Publishing) DOI:10.1039/C9NP00052F](https://pubs.rsc.org/image/article/2020/NP/c9np00052f/c9np00052f-f4_hi-res.gif)
Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products - Natural Product Reports (RSC Publishing) DOI:10.1039/C9NP00052F
![Prognostic and predictive biomarker developments in multiple myeloma | Journal of Hematology & Oncology | Full Text Prognostic and predictive biomarker developments in multiple myeloma | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01162-7/MediaObjects/13045_2021_1162_Figa_HTML.png)